期 |
标题 |
文件 |
卷 97, 编号 4 (2025): Вопросы диагностики |
MicroRNA-499a in heart diseases: prospects for use in diagnostics. A review |
 (Rus)
|
Pisklova M., Baulina N., Kiselev I., Favorova O.
|
卷 97, 编号 4 (2025): Вопросы диагностики |
Spatial vector cardiography: From origins to the present day. A review |
 (Rus)
|
Oleynikov V., Chernova A.
|
卷 97, 编号 4 (2025): Вопросы диагностики |
Strategies for choice of antiretroviral therapy in patients with HIV infection and concomitant cardiovascular disease: A review |
 (Rus)
|
Shakhgildyan V., Matskeplishvili S.
|
卷 97, 编号 4 (2025): Вопросы диагностики |
Terminal ileitis: Questions of differential diagnosis and prospects for treatment. A review |
 (Rus)
|
Osadchuk A., Golovenko O., Loranskaia I.
|
卷 97, 编号 4 (2025): Вопросы диагностики |
A novel strategy for the management of non-productive cough: mechanisms, efficacy, safety. A review |
 (Rus)
|
Kalyuzhin O., Malyavin A.
|
卷 97, 编号 3 (2025): Пульмонология |
Chronic bronchitis – new clinical recommendations (main provisions): A review on behalf of the working group for the development and revision of clinical guidelines for chronic bronchitis |
 (Rus)
|
Leshchenko I., Avdeev S., Zaytsev A., Ovcharenko S.
|
卷 97, 编号 2 (2025): Вопросы гастроэнтерологии |
Therapy for irritable bowel syndrome: focus on butylbromide hyoscine. A review |
 (Rus)
|
Goncharenko A., Gorbovskoi F., Kargina E., Kondrat'eva N.
|
卷 97, 编号 2 (2025): Вопросы гастроэнтерологии |
Prevalence and risk of malnutrition in patients with chronic pancreatitis: A systematic review and meta-analysis |
 (Rus)
|
Andreev D., Khurmatullina A., Kucheryavyy Y., Maev I.
|
卷 97, 编号 1 (2025): Поликлинические проблемы и организация медицинской помощи |
A systematic review on the safety and efficacy of metamizole sodium as a therapy for the treatment of fever in children and adults |
 (Rus)
|
Malyavin A., Babak S., Zaplatnikov A., Bulgakova V., Garusova M., Ilyukhina M.
|
卷 97, 编号 1 (2025): Поликлинические проблемы и организация медицинской помощи |
Sudden cardiac death and decompensation of heart failure: how to reduce the risks. A review |
 (Rus)
|
Kuleshova M., Uskach T., Sapelnikov O.
|
卷 96, 编号 12 (2024): VARIO (РАЗНОЕ) |
Rebamipide: thirty years of experience. A review |
 (Rus)
|
Bakulina N., Ponomarenko V., Bakulin I.
|
卷 96, 编号 12 (2024): VARIO (РАЗНОЕ) |
Efficacy of combination chondroitin sulfate plus glucosamine hydrochloride in osteoarthritis: A systematic review |
 (Rus)
|
Naumov A., Khovasova N., Unkovskiy A.
|
卷 96, 编号 11 (2024): Инфекционные заболевания |
Infant botulism: an underestimated problem. A review |
 (Rus)
|
Malov V., Maleev V., Chulanov V., Sarksyan D.
|
卷 96, 编号 11 (2024): Инфекционные заболевания |
Issues of treatment and prevention of recurrent inflammatory diseases of the upper respiratory tract: An immunologist's view. A review |
 (Rus)
|
Shul'zhenko A., Zuikova I., Shchubelko R.
|
卷 96, 编号 11 (2024): Инфекционные заболевания |
Anticoagulant therapy for chronic heart disease atrial failure and fibrillation: a review |
 (Rus)
|
Serova M., Sazonova Y., Derevinskaiia A., Steklov A., Andreev D.
|
卷 96, 编号 10 (2024): Вопросы эндокринологии |
Intermittent fasting: Effectiveness and safety. A review |
 (Rus)
|
Altashina M., Ivannikova E., Troshina E.
|
卷 96, 编号 8 (2024): Вопросы лечения |
Barth syndrome in an adult patient: an overview of the problem and case report. A review |
 (Rus)
|
Muksinova M., Osmolovskaya Y., Leontyeva I., Galaeva M., Stukalova O., Beniashvili A., Safiullina A., Zhirov I., Tereshchenko S.
|
卷 96, 编号 8 (2024): Вопросы лечения |
Hyaluronic acid in the treatment of osteoarthritis: innovations in injection therapy. A review |
 (Rus)
|
Menshikova I.
|
卷 96, 编号 8 (2024): Вопросы лечения |
Ferritin as a biomarker of aging: geroprotective peptides of standardized human placental hydrolysate. A review |
 (Rus)
|
Gromova O., Torshin I., Chuchalin A.
|
卷 96, 编号 8 (2024): Вопросы лечения |
Herbal extracts in hepatoprotection: antioxidant and immunomodulatory effects. A review |
 (Rus)
|
Shikh E., Khaytovich E., Tsvetkov D.
|
卷 96, 编号 7 (2024): VARIO |
4D flow MRI: value and clinical perspectives in patients with pathology of the heart and great vessels (part 2): A review |
 (Rus)
|
Yurpolskaya L.
|
卷 96, 编号 7 (2024): VARIO |
Dyspnea in post-COVID-19 patients: A review |
 (Rus)
|
Podzolkov V., Vetluzhskaya M., Medvedev I., Abramova A., Kislenko G.
|
卷 96, 编号 6 (2024): Нефрология |
Lupus nephritis and thrombotic microangiopathy: A review |
 (Rus)
|
Bobrova L., Kozlovskaya N.
|
卷 96, 编号 5 (2024) |
Chronic hepatitis B in rheumatic diseases: issues of screening and reactivation of infection: A review |
 (Rus)
|
Gridneva G., Belov B., Aronova E.
|
卷 96, 编号 5 (2024) |
Current challenges for therapy of comorbid patients: a new look at celecoxib. A review |
 (Rus)
|
Zyryanov S., Baybulatova E.
|
卷 96, 编号 5 (2024) |
Current treatment for spondyloarthritis: focus on netakimab. A review |
 (Rus)
|
Karateev D., Luchikhina E.
|
卷 96, 编号 4 (2024) |
4D flow MRI: value and clinical perspectives in patients with pathology of the heart and great vessels. A review |
 (Rus)
|
Yurpolskaya L.
|
卷 96, 编号 4 (2024) |
Status and trends of legislative and regulatory regulation of off-label use of drugs: A review |
 (Rus)
|
Zakharochkina E., Ryazhenov V., Smolyarchuk E., Kudlay D., Bekhorashvili N., Zaveryachev S., Sologova S.
|
卷 96, 编号 4 (2024) |
Selection of parenteral iron supplement for iron deficiency anemia: A review |
 (Rus)
|
Zyryanov S., Baybulatova E.
|
卷 96, 编号 4 (2024) |
Comparative analysis of the drugs efficacy for carbohydrate metabolism early disorders (prediabetes) treatment: A review |
 (Rus)
|
Mkrtumyan A.
|
卷 96, 编号 4 (2024) |
The clinician's view on the advantages and contradictions of the new nomenclature of steatotic liver disease: A review |
 (Rus)
|
Pavlov C., Teplyuk D., Lazebnik L., Ametov A., Pashkova E., Sorokoletov S., Uspenskiy Y., Turkina S., Ponomarenko E., Maslakov A.
|
卷 96, 编号 3 (2024) |
New clinical guidelines for COPD – a paradigm shift: A review |
 (Rus)
|
Avdeev S., Leshchenko I., Aisanov Z., Arkhipov V., Belevskiy A., Ovcharenko S., Emelyanov A., Sinopalnikov A., Shmelev E., Chuchalin A.
|
卷 96, 编号 3 (2024) |
Pulmonary fibrosis after a new coronavirus infection – versions and controversies: A review |
 (Rus)
|
Shchepikhin E., Shmelev E., Ergeshov A.
|
卷 96, 编号 3 (2024) |
Blood eosinophilia in patients with severe bronchial asthma and chronic polypous rhinosinusitis treated with dupilumab: A review |
 (Rus)
|
Petukhova A., Gromov A., Solovyov R., Filippova S., Prokopieva E.
|
卷 96, 编号 2 (2024) |
New possibilities of antiarrhythmic therapy of atrial fibrillation: A review |
 (Rus)
|
Tarzimanova A., Isaeva A.
|
卷 96, 编号 2 (2024) |
Classification of chronic gastritis: historical digression and current state of the issue. A review |
 (Rus)
|
Livzan M., Bordin D., Gaus O., Lisovskiy M., Mozgovoi S., Kononov A.
|
卷 96, 编号 2 (2024) |
Risk factors for irritable bowel syndrome: A review |
 (Rus)
|
Gaus O., Livzan M., Gavrilenko D.
|
卷 96, 编号 2 (2024) |
Multifactorial effects of Lactobacillus paracasei DG in the regulation of the microbial-tissue complex: A review |
 (Rus)
|
Zakharenko S.
|
卷 96, 编号 2 (2024) |
Fixed combination of non-steroidal anti-inflammatory drug and muscle relaxant as the basis for rational therapy of pain syndromes: A review |
 (Rus)
|
Putilina M.
|
卷 95, 编号 12 (2023) |
Therapy of degenerative changes in the ankle joint with US-guided linear hyaluronic acid injections. A review |
 (Rus)
|
Devald I., Khodus E.
|
卷 96, 编号 1 (2024) |
Pharmacogenetics of dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes mellitus: A review |
 (Rus)
|
Samoilova I., Vaizova O., Stankova A., Matveeva M., Podchinenova D., Kudlay D., Borozinets A., Filippova T., Grishkevich I., Partala A., Gerasimova D.
|
卷 96, 编号 1 (2024) |
Therapies of chronic thromboembolic pulmonary hypertension: A review |
 (Rus)
|
Vasiltseva O., Edemskiy A., Zeinalov D., Kliver E., Ussov W., Grankin D., Sirota D., Chernyavskiy A.
|
卷 95, 编号 12 (2023) |
Pulmonary heart: A review |
 (Rus)
|
Chuchalin A.
|
卷 95, 编号 12 (2023) |
Vascular complications of diabetes mellitus worldwide and in Russia: The path of 100 years. A review |
 (Rus)
|
Shestakova M., Severina A.
|
卷 95, 编号 12 (2023) |
Current antiretroviral therapy: A review |
 (Rus)
|
Kravchenko A., Maleyev V.
|
卷 95, 编号 12 (2023) |
Ways for reducing mortality from cardiovascular diseases: A review |
 (Rus)
|
Boytsov S.
|
卷 95, 编号 12 (2023) |
Autoimmunity in rheumatology: A review |
 (Rus)
|
Nasonov E.
|
卷 95, 编号 12 (2023) |
Inflammatory bowel diseases: Transformation of representations. A review |
 (Rus)
|
Maev I., Bakulin I., Skalinskaya M., Skazyvaeva E.
|
卷 95, 编号 12 (2023) |
State-of-the-art trends in the treatment of immune-mediated inflammatory kidney diseases: Translation of the fundamental science into clinical practice. A review |
 (Rus)
|
Bulanov N., Moiseev S.
|
卷 95, 编号 12 (2023) |
V. N. Vinogradov Faculty Therapy Clinic of Sechenov University: the flagship of the therapeutic service of the Russian Federation. A review |
 (Rus)
|
Fomin V., Blagova O., Morozova N., Serdyuk M., Royuk V.
|
卷 95, 编号 12 (2023) |
Reunion of the main Russian schools of internal medicine: on the occasion of the centenary of the Therapeutic Archive journal. A review |
 (Rus)
|
Zhirov I.
|
卷 95, 编号 12 (2023) |
Chronic thromboembolic pulmonary hypertension: current diagnostic and treatment options: A review |
 (Rus)
|
Chazova I.
|
卷 95, 编号 12 (2023) |
Modern concept of differential diagnosis of colitis: from G.F. Lang to the present day. A review |
 (Rus)
|
Parfenov A., Kagramanova A., Khomeriki S., Kulakov D.
|
卷 95, 编号 11 (2023) |
Сardiac arrhythmias in people who have had a coronavirus infection COVID-19: A review |
 (Rus)
|
Yamoldinov N., Dudarev M., Sarksyan D., Maleev V.
|
卷 95, 编号 11 (2023) |
Diagnosis and antibiotic therapy of nosocomial pneumonia in adults: from recommendations to real practice. A review |
 (Rus)
|
Rachina S., Fedina L., Sukhorukova M., Sychev I., Larin E., Alkhlavov A.
|
卷 95, 编号 11 (2023) |
Pathogenetic approaches to the correction of vascular homeostasis in patients with COVID-19: A review |
 (Rus)
|
Shuldyakov A., Smagina A., Ramazanova K., Lyapina E., Chabbarov Y., Sheshina N., Zhuk A.
|
卷 95, 编号 10 (2023) |
Advantages of glucagon-like peptide-1 receptor agonists in the treatment of patients with type 2 diabetes mellitus: A review |
 (Rus)
|
Demidova T., Titova V., Izmaylova M.
|
卷 95, 编号 10 (2023) |
Autoimmune polyendocrine syndrome in adults. Focus on rheumatological aspects of the problem: A review |
 (Rus)
|
Panevin T., Zotkin E., Troshina E.
|
卷 95, 编号 10 (2023) |
Non-alcoholic fatty liver disease: aspects of management of a comorbid patient. A review |
 (Rus)
|
Demidova T., Ushanova F.
|
卷 95, 编号 9 (2023) |
The role of mineralocorticoid receptors hyperactivation in the development of cardiorenal complications in patients with diabetes mellitus, perspective of the selective nonsteroidal mineralocorticoid receptors antagonist’s treatment: A review |
 (Rus)
|
Bobkova I.
|
卷 95, 编号 9 (2023) |
Sacubitril/valsartan in patients with mildly reduced or preserved ejection fraction and worsening heart failure: A review |
 (Rus)
|
Zhirov I., Safronova N., Tereshchenko S.
|
卷 95, 编号 9 (2023) |
Sartans in the treatment of arterial hypertension: focus on telmisartan and azilsartan. A review |
 (Rus)
|
Zakiev V., Kotovskaya Y., Tkacheva O.
|
卷 95, 编号 8 (2023) |
Eosinophilic chronic obstructive pulmonary disease: A review |
 (Rus)
|
Anaev E.
|
卷 95, 编号 8 (2023) |
Prospects of dietary fibers food fortification for the treatment and prevention of gastrointestinal diseases: A review |
 (Rus)
|
Pilipenko V., Perova I., Kochetkova A., Isakov V.
|
卷 95, 编号 8 (2023) |
Anxiety in subjects with cardiovascular disease: Current diagnostic strategies and therapeutic options. A review |
 (Rus)
|
Shishkova V.
|
卷 95, 编号 8 (2023) |
Clinical effectiveness and pharmacokinetics of gliflozin from the point of view of individual genetic characteristics: A review |
 (Rus)
|
Golovina E., Vaizova O., Meleshko M., Samoilova I., Podchinenova D., Borozinets A., Matveeva M., Kudlay D.
|
卷 95, 编号 8 (2023) |
Current status and prospects of using the prokinetic acotiamide in gastroenterology: A review |
 (Rus)
|
Maev I., Andreev D., Zaborovsky A., Lobanova E.
|
卷 95, 编号 7 (2023) |
Diseases of the gastrointestinal tract in the context of COVID-19 infection: present and future challenges: A review |
 (Rus)
|
Maev I., Osadchuk M.
|
卷 95, 编号 7 (2023) |
Vaping and vaping-associated lung injury: A review |
 (Rus)
|
Podzolkov V., Vetluzhskaya M., Abramova A., Ishina T., Garifullina K.
|
卷 95, 编号 6 (2023) |
Frailty and chronic kidney disease – the real problem of modern nephrology: A review |
 (Rus)
|
Rudenko T., Bobkova I., Kamyshova E., Stavrovskaya E.
|
卷 95, 编号 5 (2023) |
Hypogonadism syndrome in men with inflammatory joint diseases: A review |
 (Rus)
|
Panevin T., Rozhivanov R., Nasonov E.
|
卷 95, 编号 5 (2023) |
Structural and functional characteristics of the brain and their role in the development of eating behaviour in obesity: A review |
 (Rus)
|
Samoilova I., Podchinenova D., Matveeva M., Kudlay D., Oleynik O., Tolmachev I., Kaverina I., Vachadze T., Kovarenko M., Loginova O.
|
卷 95, 编号 5 (2023) |
The use of sodium hyaluronate to treat upper limb disease: A review |
 (Rus)
|
Filatova Y., Ilyin M.
|
卷 95, 编号 4 (2023) |
Modern methods of assessment of physiological significance of coronary lesions: A review |
 (Rus)
|
Mironova O., Isaev G., Berdysheva M., Shakhnovich R., Fomin V.
|
卷 95, 编号 4 (2023) |
Tactics of anticoagulant therapy in patients with cardiac implantable electronic devices and subclinical atrial fibrillation: A review |
 (Rus)
|
Razina T., Serova M., Andreev D., Sazonova Y., Komarova A.
|
卷 95, 编号 3 (2023) |
Progressive fibrosing lung disease. Discussion aspects of the problem: A review |
 (Rus)
|
Ilkovich M., Novikova L., Speranskaya A., Dvorakovskaya I.
|
卷 95, 编号 3 (2023) |
Finerenone cardiorenal effects and its placement in treatment of chronic kidney disease in patients with type 2 diabetes mellitus: A review |
 (Rus)
|
Salukhov V., Shamkhalova M., Duganova A.
|
卷 95, 编号 3 (2023) |
Genetic aspects of type 1 glucagon peptide agonists clinical efficacy: A review |
 (Rus)
|
Golovina E., Grishkevich I., Vaizova O., Samoilova I., Podchinenova D., Matveeva M., Kudlay D.
|
卷 95, 编号 2 (2023) |
Principles of treatment of different forms of alcoholic liver disease: A review |
 (Rus)
|
Raikhelson K., Kondrashina E., Pazenko E.
|
卷 95, 编号 1 (2023) |
Antibiotic resistance – what can be done? A review |
 (Rus)
|
Kisil O., Gabrielyan N., Maleev V.
|
卷 95, 编号 1 (2023) |
Functional methods of amyloid cardiomyopathy diagnostic in practice and in expert centers: A review |
 (Rus)
|
Dzhioeva O.
|
卷 94, 编号 12 (2022) |
Hyperuricemia and kidney damage in patients with cardiovascular disease: A review |
 (Rus)
|
Mironova O.
|
卷 94, 编号 12 (2022) |
Pharmacokinetics and pharmacodynamics of rebamipide. New possibilities of therapy: A review |
 (Rus)
|
Bakulina N., Tikhonov S., Okovityi S., Lutaenko E., Bolshakov A., Prikhodko V., Nekrasova A.
|
卷 94, 编号 12 (2022) |
Ferroptosis-associated lesion as a potential target for cardiovascular disease: A review |
 (Rus)
|
Podzolkov V., Tarzimanova A., Ponomareva L., Popova E., Ponomarev A.
|
卷 94, 编号 11 (2022) |
Liver disease during the pandemic of COVID-19 infection: prediction of the course and tactics of management: A review |
 (Rus)
|
Maev I., Osadchuk M.
|
卷 94, 编号 11 (2022) |
Pulmonary fibrosis in patients with COVID-19: A review |
 (Rus)
|
Chuchalin A.
|
卷 94, 编号 10 (2022) |
New opportunities of antithrombotic therapy in patients with type 2 diabetes mellitus and stable coronary heart disease for reducing the cardiovascular risk and cardiovascular complications: THEMIS, THEMIS-PCI trials |
 (Rus)
|
Kalashnikov V., Michurova M.
|
卷 94, 编号 10 (2022) |
Social and psychological risk factors for decreased adherence among patients with atrial fibrillation |
 (Rus)
|
Troshina D., Andreev D., Fomicheva A., Volovchenko A., Volel B.
|
卷 94, 编号 10 (2022) |
Sub-analyses of the DAPA-CKD study: new data on the use of sodium-glucose cotransporter type 2 inhibitor in the treatment of chronic kidney disease |
 (Rus)
|
Shamkhalova M., Sukhareva O., Shestakova M.
|
卷 94, 编号 10 (2022) |
Intermittent fasting: endocrine aspects: A review |
 (Rus)
|
Altashina M., Ivannikova E., Troshina E.
|
卷 94, 编号 9 (2022) |
Heart failure and obesity |
 (Rus)
|
Safiullina A., Uskach T., Saipudinova K., Tereshchenko S., Chazova I.
|
卷 94, 编号 8 (2022) |
Modern extemporaneous formulations in the geriatric care management: current opportunities and future challenges. A review |
 (Rus)
|
Korol L., Egorova S., Kudlay D., Krasnyuk I., Sologova S., Korol V., Smolyarchuk E., Sadkovskii I., Mandrik M.
|
卷 94, 编号 8 (2022) |
Hyaluronic acid in the treatment of osteoarthritis of various localization: A review |
 (Rus)
|
Filatova Y., Soloviev I.
|
卷 94, 编号 8 (2022) |
Rationale for choosing an antibiotic for the treatment of cystitis: recommendations of clinical pharmacologists: A review |
 (Rus)
|
Yakovlev S., Suvorova M.
|
卷 94, 编号 8 (2022) |
Role of interleukin-1 in human diseases: pharmacotherapy prospects: A review |
 (Rus)
|
Nasonov E.
|
卷 94, 编号 7 (2022) |
Features of the intestine conditions at patients with a new coronavirus infection |
 (Rus)
|
Topchiy T., Ardatskaya M., Butorova L., Маslovskii L., Мinushkin О.
|
卷 94, 编号 7 (2022) |
Problems associated with effective pharmacotherapy of the elderly patients (geriatrics): A review |
 (Rus)
|
Korol L., Egorova S., Kudlay D., Krasnyuk I., Sologova S., Korol V., Smolyarchuk E., Mandrik M.
|
卷 94, 编号 7 (2022) |
Stress-induced arterial hypertension |
 (Rus)
|
Ambatiello L.
|
卷 94, 编号 7 (2022) |
Rehabilitation in patients with chronic thromboembolic pulmonary hypertension |
 (Rus)
|
Sagaydak O., Danilov N., Chazova I.
|
卷 94, 编号 6 (2022) |
Modern view on the complement system role in membranous nephropathy |
 (Rus)
|
Kamyshova E., Semeryuk T., Bobkova I.
|
卷 94, 编号 5 (2022) |
On the specific treatment of asthenic states: focus on sulbutiamine |
 (Rus)
|
Bykov Y., Bekker R.
|
卷 94, 编号 5 (2022) |
Endogenous estrogen deficiency and the development of chronic musculoskeletal pain: A review |
 (Rus)
|
Panevin T., Bobkova A., Karateev A., Zotkin E.
|
卷 94, 编号 4 (2022) |
Practical guidelines for the diagnosis and treatment of transthyretin amyloid cardiomyopathy (ATTR-CM or transthyretin cardiac amyloidosis) |
 (Rus)
|
Tereshchenko S., Zhirov I., Moiseeva O., Adasheva T., Ansheles A., Barbarash O., Galyavich A., Gudkova A., Zateyshchikov D., Kostareva A., Nasonova S., Nedogoda S., Pecherina T., Ryzhkova D., Sergienko V.
|
卷 94, 编号 4 (2022) |
The risk of developing cardiovascular disease in bipolar disorder. Biological factors and therapy |
 (Rus)
|
Mosolov S., Fedorova E.
|
卷 94, 编号 4 (2022) |
Management of iron deficiency in chronic heart failure |
 (Rus)
|
Uskach T.
|
卷 94, 编号 4 (2022) |
SGLT2 inhibitors in acute decompensated heart failure, what do we know? |
 (Rus)
|
Lapteva A., Nasonova S., Zhirov I., Tereshchenko S.
|
卷 94, 编号 4 (2022) |
Non-compact right ventricular myocardium – diagnostic and clinical features: A review |
 (Rus)
|
Oleynikov V., Donetskaya N., Vdovkin A., Babina A., Avdeeva I.
|
卷 94, 编号 4 (2022) |
The role of cardiac magnetic resonance imaging in defining the prognosis of patients with acute ST-segment elevation myocardial infarction. Part 2. Assessment of the disease prognosis |
 (Rus)
|
Terenicheva M., Stukalova O., Shakhnovich R., Ternovoy S.
|
卷 94, 编号 3 (2022) |
Risk of community acquired pneumonia in patients with diabetes mellitus: Review |
 (Rus)
|
Ignatova G., Blinova E., Struch S., Syrochkina M.
|
卷 94, 编号 3 (2022) |
Respiratory diseases and obesity: special phenotype or independent events: Review |
 (Rus)
|
Shchepikhin E., Shmelev E., Zaytseva A.
|
卷 94, 编号 3 (2022) |
Human placenta hydrolysates: from V.P. Filatov to the present day: Review |
 (Rus)
|
Gromova O., Torshin I., Chuchalin A., Maximov V.
|
卷 94, 编号 2 (2022) |
Pancreatic cancer risk: alcoholic and non-alcoholic beverages |
 (Rus)
|
Grigor’eva I.
|
卷 94, 编号 2 (2022) |
Erosive and ulcerative lesions of the digestive tract: optimization of diagnosis and management tactics |
 (Rus)
|
Osadchuk M., Osadchuk A.
|
卷 94, 编号 2 (2022) |
Correction of intestinal microbial composition disturbances as a potential link in complex therapy of patients with COVID-19 |
 (Rus)
|
Akhmedov V.
|
卷 94, 编号 1 (2022) |
Primary hyperaldosteronism: indications for screening |
 (Rus)
|
Chikhladze N.
|
卷 94, 编号 1 (2022) |
Headaches in general medical practice |
 (Rus)
|
Tabeeva G.
|
卷 94, 编号 1 (2022) |
PROM a contemporary approach to assessing the quality of life of patients with cancer |
 (Rus)
|
Khatkov I., Minaeva O., Domrachev S., Priymak M., Solovyev N., Tyutyunnik P.
|
卷 94, 编号 1 (2022) |
Venous thromboembolic complications in patients with chronic kidney disease: prevalence and features of drug treatment |
 (Rus)
|
Dzhioeva O., Orlova A., Rogozhkina E., Drapkina O.
|
卷 93, 编号 12 (2021) |
Functional dyspepsia: a multifaceted problem in gastroenterology |
 (Rus)
|
Osadchuk M., Svistunov A., Balashov D., Osadchuk M.
|
卷 93, 编号 12 (2021) |
Treatment strategies for patients with atrial fibrillation and chronic heart failure |
 (Rus)
|
Tereshchenko S., Uskach T.
|
卷 93, 编号 12 (2021) |
Chondroitin sulfate in therapy osteoarthritis chronic pain patients according to actual clinical recommendations |
 (Rus)
|
Shavlovskaya O.
|
卷 93, 编号 12 (2021) |
The risk of developing cardiovascular disease in bipolar disorder. Clinical and social factors |
 (Rus)
|
Mosolov S., Fedorova E.
|
卷 93, 编号 12 (2021) |
Atherosclerosis and cardiovascular risk in patients with inflammatory bowel disease |
 (Rus)
|
Mironova O., Isaikina M., Khasieva S.
|
卷 93, 编号 11 (2021) |
Adrenal incidentaloma. Part 2. Modern concepts of computed tomography semiotics of adrenal gland incidentalomas: algorithm of differential diagnosis |
 (Rus)
|
Buryakina S., Tarbaeva N., Volevodz N., Karmazanovsky G., Kovalevich L., Shestakova M., Dedov I.
|
卷 93, 编号 11 (2021) |
Pro-inflammatory cytokines in chronic cardiac failure: state of problem |
 (Rus)
|
Korotaeva A., Samoilova E., Mindzaev D., Nasonova S., Zhirov I., Tereschenko S.
|
卷 93, 编号 11 (2021) |
The role and place of pathogenetic therapy with glucocorticosteroid hormones in the treatment of patients with novel coronavirus infection (COVID-19) |
 (Rus)
|
Efremov D., Beloborodov V.
|
卷 93, 编号 11 (2021) |
Varicella-pox virus infection: features of the course, clinical manifestations, complications, and possibilities for prevention |
 (Rus)
|
Prikhodchenko N.
|
卷 93, 编号 10 (2021) |
Primary hyperparathyroidism and vitamin D deficiency |
 (Rus)
|
Runova G., Golounina O., Glinkina I., Fadeev V.
|
卷 93, 编号 10 (2021) |
Mineral metabolism and COVID-19: is there a connection? |
 (Rus)
|
Maganeva I., Gorbacheva A., Bibik E., Aboisheva E., Eremkina A., Mokrysheva N.
|
卷 93, 编号 10 (2021) |
Hyperprolactinemia in the postmenopause: versions and contraversions |
 (Rus)
|
Leshchenko O.
|
卷 93, 编号 10 (2021) |
Prevention of ischemic stroke in atrial fibrillation from the point of view of a neurologist. Standards and real clinical practice |
 (Rus)
|
Maksimova M., Fonyakin A., Geraskina L.
|
卷 93, 编号 9 (2021) |
COVID-19 and features of cardiovascular involvement |
 (Rus)
|
Tsyganova E., Glukhoedova N., Zhilenkova A., Fedoseeva T., Iushchuk E., Smetneva N.
|
卷 93, 编号 9 (2021) |
Influenza vaccination and prognosis for patients with high cardiovascular risk |
 (Rus)
|
Dmitrieva O., Mironova O., Fomin V.
|
卷 93, 编号 9 (2021) |
Evidence base for specific pulmonary vasodilators in adults with congenital heart disease |
 (Rus)
|
Shmalts A., Gorbachevsky S.
|
卷 93, 编号 9 (2021) |
Optimization of specific therapy for pulmonary hypertension: the possibilities of riociguat |
 (Rus)
|
Martynyuk T., Shmalts A., Gorbachevsky S., Chazova I.
|
卷 93, 编号 9 (2021) |
Tactics of antihypertensive therapy during COVID-19 pandemic |
 (Rus)
|
Podzolkov V., Bragina A., Rodionova Y., Bragina G., Bykova E.
|
卷 93, 编号 9 (2021) |
New clinical opportunities for mineralocorticoid receptor antagonists: focus on antifibrotic effects |
 (Rus)
|
Dragomiretskaya N., Tarzimanova A., Kucherova J., Podzolkov V.
|
卷 93, 编号 8 (2021) |
Rational treatment of patients with functional dyspepsia |
 (Rus)
|
Kazakov A., Zyryanov S., Ushkalova E., Nasretdinova E.
|
卷 93, 编号 8 (2021) |
Combine therapy as a modern approach to treatment of allergic rhinitis |
 (Rus)
|
Emelyanov A.
|
卷 93, 编号 8 (2021) |
Roles of active forms of vitamin D in supporting innate immune systems and in reducing excess inflammation in COVID-19 |
 (Rus)
|
Gromova O., Torshin I., Chuchalin A., Kozhevnikova E., Malyavskaya S.
|
卷 93, 编号 8 (2021) |
Obesity as a risk factor for diseases of the digestive system |
 (Rus)
|
Andreev D., Kucheryavyy Y.
|
卷 93, 编号 8 (2021) |
Liver cirrosis and complication risk management |
 (Rus)
|
Bakulin I., Oganezova I., Skalinskaya M., Skazyvaeva E.
|
卷 93, 编号 8 (2021) |
The role of visceral hypersensitivity in the pathogenesis of irritable bowel syndrome |
 (Rus)
|
Makarova A., Ruchkina I., Parfenov A., Indeykina L., Romashkina N.
|
卷 93, 编号 8 (2021) |
Is histological remission of ulcerative colitis achievable? |
 (Rus)
|
Knyazev O., Kagramanova A., Khomeriki S., Parfenov A.
|
卷 93, 编号 7 (2021) |
Treatment of thrombotic thrombocytopenic purpura |
 (Rus)
|
Galstyan G., Maschan A., Klebanova E., Kalinina I.
|
卷 93, 编号 6 (2021) |
Role of the intestinal MALT in pathogenesis of the IgA-nephropathy |
 (Rus)
|
Guliaev S., Strizhakov L., Chebotareva N., Moiseev S.
|
卷 93, 编号 6 (2021) |
The value of a low-protein diet and ketoanalogues of essential amino acids in the сontrol of protein carbamylation and toxic effects of urea in chronic kidney disease |
 (Rus)
|
Mikhailova N.
|
卷 93, 编号 6 (2021) |
Treatment of thrombotic thrombocytopenic purpura |
 (Rus)
|
Galstyan G., Maschan A., Klebanova E., Kalinina I.
|
卷 93, 编号 5 (2021) |
Locomotive syndrome: from paradigms to clinical reality |
 (Rus)
|
Putilina M., Teplova N., Lila A., Zagorodniy N.
|
卷 93, 编号 5 (2021) |
Modern approaches to immunization of patients of rheumatologic profile |
 (Rus)
|
Belov B., Tarasova G., Muravyeva N.
|
1 - 150 的 200 信息 |
1 2 > >>
|